DLB
Dolby Laboratories
58.60$
+1.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 12.2% | 10.2% | 10.6% | 12.3% | 11.2% | 11.4% | 9.7% | 13.9% | 12.9% | 12.5% | 11.3% | 13.2% | 12.4% | |
| 87.8% | 89.8% | 89.4% | 87.7% | 88.8% | 88.6% | 90.3% | 86.1% | 87.1% | 87.5% | 88.7% | 86.8% | 87.6% | |
| 24.2% | 21.2% | 17.1% | 22.7% | 22.5% | 18.7% | 16.7% | 20.9% | 22.0% | 19.9% | 16.1% | 21.6% | 19.6% | |
| 22.9% | 20.6% | 18.3% | 24.0% | 22.7% | 19.6% | 19.1% | 22.9% | 24.0% | 20.3% | 19.2% | 24.8% | 21.8% | |
| 78.4% | 66.9% | 60.2% | 73.5% | 74.1% | 64.7% | 60.0% | 71.0% | 77.5% | 69.6% | 59.6% | 74.2% | 69.5% | |
| 9.3% | 22.9% | 29.2% | 14.1% | 14.8% | 23.8% | 30.3% | 15.1% | 9.7% | 17.9% | 29.1% | 12.5% | 18.1% | |
| – | – | – | – | – | – | – | – | – | 1.2% | 1.3% | 1.1% | – | |
| 3.1% | 25.6% | 33.4% | 17.4% | 19.6% | 24.1% | 32.5% | 17.6% | 13.6% | 20.7% | 30.3% | 14.4% | 20.4% | |
| -0.3% | 4.2% | 6.5% | 3.6% | 0.3% | 5.0% | 7.6% | 2.8% | -2.6% | 5.2% | 6.1% | 4.8% | 3.6% | |
| 3.2% | 21.2% | 26.8% | 13.3% | 19.2% | 19.0% | 24.8% | 14.6% | 16.1% | 15.4% | 24.0% | 9.4% | 16.7% | |
| 11.5% | 32.3% | 39.1% | 24.7% | 27.6% | 31.2% | 39.1% | 22.7% | 19.7% | 29.6% | 37.0% | 20.8% | 27.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.